Phase 1 Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are able to understand and sign a written consent form agreeing to take part in the trial and all its procedures
- People aged 18 or older (for the first part of the trial, participants must be between 18 and 75 years old)
- People whose general physical health and ability to carry out daily activities is rated as good or fully active (scored 0 or 1 on a standard medical scale)
- People with a life expectancy of at least 12 weeks
- People whose liver, kidneys, and other organs are working well enough, as confirmed by tests done at the start of the trial
- People who have been diagnosed through laboratory testing with small cell lung cancer (SCLC) that cannot be removed by surgery, has spread to other parts of the body, or is at an advanced stage
Who may not be able to join:
- People who are currently taking part in another clinical trial that involves an active treatment or intervention (observational studies or follow-up phases of a previous trial may be acceptable — confirm with trial site)
- People who still have side effects from previous cancer treatments that have not improved to a mild or resolved level, with some exceptions such as hair loss or fatigue that the doctor considers low risk
- People with a known allergy or sensitivity to the study drug IBI3009 or any of its ingredients
- People who have had major surgery (such as brain, chest, or abdominal surgery) within the 4 weeks before starting the trial, who are expected to have major surgery during the trial, or who have serious wounds, injuries, or ulcers that have not healed
- People who are pregnant, have a positive pregnancy test, or are currently breastfeeding
- People who the trial doctor considers unsuitable to participate for any other reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 18507159591
Australian sites
0422 050 656
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
3 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Numbers of subjects with adverse events; Number of subjects with clinically significant changes in physical examination results; Number of subjects with clinically significant changes in electrocardiogram; Number of subjects with clinically significant changes in vital signs; Dose limiting toxicities (DLTs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.